News archive for Centre for Cancer Biomarkers CCBIO

Illustration of two medical workers discussing over MRI pictures.

New imaging center on campus (28.11.2017)

A new imaging center on campus with state-of-the-art imaging equipment will strengthen research activities. Three research projects have received funding to be integrated with the novel Medical Imaging and Visualisation Centre.

Group photo of the candidate with opponents and supervisors.

Targeted treatment for uterine carcinoma (16.11.2017)

Mari Kyllesø Halle defended her thesis "Molecular alterations suggesting new treatment strategies in uterine carcinomas" at the University of Bergen November 10th 2017.

pop art illustration of people in dialogue, not agreeing.

The Science-Society Interface Discussed at FEBS Meeting in Barcelona (14.11.2017)

How do we achieve a real dialogue between Science and Society? What are scientists' responsibilities in this regard? These questions were discussed at a Round Table event 26 October 2017 at the "FEBS3+" conference in Barcelona, gathering biochemists and life scientists from France, Portugal and Spain.

Support from the Cancer Society to three of CCBIO's research projects (14.11.2017)

The Norwegian Cancer Society has recently announced their 2017-funding. The University of Bergen and Haukeland University Hospital receive 54,7 million NOK, of which 23,2 million go to CCBIO projects.

Biomarkers in aggressive breast cancer (13.11.2017)

Kristi Krüger defended November 8th her dissertation “Markers of angiogenesis and the basal-like phenotype of breast cancer”. The study has given increased knowledge of the aggressive basaloid type of breast cancer.

Ingvild Løberg Tangen posing with her diploma.

Best oral presentation prize at the ESGO to CCBIO postdoc (09.11.2017)

Postdoc in the Bergen Gynecologic Cancer Research Group, Ingvild Løberg Tangen, was awarded with the best oral presentation prize at the ESGO (European Society of Gynaecological Oncology) congress for the presentation : “Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients”.

The doctorate Marit Valla and the evaluation committee.

Better understanding of breast cancer (09.11.2017)

Marit Valla defended October 12th 2017 her PhD dissertation "Molecular subtypes of breast cancer: incidence and prognosis". This was a collaboration project between the Centre for Cancer Biomarkers (CCBIO), University of Bergen (UiB), and the Department of Public Health and Nursing, the Norwegian University of Science and Technology (NTNU).